BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 1833016)

  • 1. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL; Atasoylu AA
    Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CD4 and CD8 T cells in the graft-versus-leukemia response in Rauscher murine leukemia.
    OKunewick JP; Kociban DL; Machen LL; Buffo MJ
    Bone Marrow Transplant; 1991 Dec; 8(6):445-52. PubMed ID: 1686416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo.
    Johnson BD; Truitt RL
    Transplantation; 1992 Jul; 54(1):104-12. PubMed ID: 1631918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and suppression of delayed-type hypersensitivity to non-MHC antigens during lethal graft-versus-host reaction.
    Pritchard LL; Huchet R; Bruley-Rosset M; Riché N; Mishal Z; Halle-Pannenko O
    J Immunol; 1992 Jul; 149(1):45-52. PubMed ID: 1351502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.
    Sykes M; Bukhari Z; Sachs DH
    Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsuzaki G; Nomoto K
    J Immunol; 1990 Jul; 145(2):505-9. PubMed ID: 2114441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD.
    Sykes M; Sheard M; Sachs DH
    J Immunol; 1988 Oct; 141(7):2282-8. PubMed ID: 3049804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.
    Sykes M; Sharabi Y; Sachs DH
    Bone Marrow Transplant; 1988 Sep; 3(5):379-86. PubMed ID: 3056545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.
    Abraham VS; Sachs DH; Sykes M
    J Immunol; 1992 Jun; 148(12):3746-52. PubMed ID: 1534824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cells.
    Bruley-Rosset M; Miconnet I; Canon C; Halle-Pannenko O
    J Immunol; 1990 Dec; 145(12):4046-52. PubMed ID: 1701781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of various T cell subtypes on GVHD in a murine model for MHC-matched unrelated donor transplant.
    OKunewick JP; Kociban DL; Buffo MJ
    Bone Marrow Transplant; 1990 Mar; 5(3):145-52. PubMed ID: 1691938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.
    Palathumpat V; Dejbakhsh-Jones S; Holm B; Strober S
    J Immunol; 1992 Aug; 149(3):808-17. PubMed ID: 1386094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selective donor T-cell depletion on the graft-versus-leukemia reaction in allogeneic marrow transplantation.
    OKunewick J; Kociban D; Machen L; Buffo M
    Transplant Proc; 1992 Dec; 24(6):2998-9. PubMed ID: 1361270
    [No Abstract]   [Full Text] [Related]  

  • 18. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
    Sharabi Y; Abraham VS; Sykes M; Sachs DH
    Bone Marrow Transplant; 1992 Mar; 9(3):191-7. PubMed ID: 1387333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma.
    Truitt RL; Shih CC; LeFever AV
    Transplantation; 1986 Mar; 41(3):301-10. PubMed ID: 3513389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
    Krzystyniak K; Panaye G; Descotes J; Revillard JP
    Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.